G. Matthew Vail

511 total citations
12 papers, 366 citations indexed

About

G. Matthew Vail is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Matthew Vail has authored 12 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Matthew Vail's work include Sepsis Diagnosis and Treatment (6 papers), Sexual function and dysfunction studies (3 papers) and Fungal Infections and Studies (3 papers). G. Matthew Vail is often cited by papers focused on Sepsis Diagnosis and Treatment (6 papers), Sexual function and dysfunction studies (3 papers) and Fungal Infections and Studies (3 papers). G. Matthew Vail collaborates with scholars based in United States, United Kingdom and Egypt. G. Matthew Vail's co-authors include Douglas J. Haney, Mark D. Williams, Gordon R. Bernard, Jean‐Louis Vincent, Ronald S. Filo, Michiel E. Stegenga, Tom van der Poll, R. S. Young, L. Joseph Wheat and Kenneth Cornetta and has published in prestigious journals such as Critical Care Medicine, The American Journal of Cardiology and Critical Care.

In The Last Decade

G. Matthew Vail

11 papers receiving 355 citations

Peers

Countries citing papers authored by G. Matthew Vail

Since Specialization

Citations

This map shows the geographic impact of G. Matthew Vail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Matthew Vail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Matthew Vail more than expected).

Fields of papers citing papers by G. Matthew Vail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Matthew Vail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Matthew Vail. The network helps show where G. Matthew Vail may publish in the future.

Co-authorship network of co-authors of G. Matthew Vail

This figure shows the co-authorship network connecting the top 25 collaborators of G. Matthew Vail. A scholar is included among the top collaborators of G. Matthew Vail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Matthew Vail. G. Matthew Vail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Severe Protein C Deficiency is Associated With Organ Dysfunction in Patients With Severe Sepsis 2012 ·Survey of Anesthesiology ·Andrew Shaw, G. Matthew Vail, Douglas J. Haney, (unknown), Mark D. Williams	1
2	Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis 2011 ·Journal of Critical Care ·Andrew Shaw, G. Matthew Vail, Douglas J. Haney, (unknown), Mark D. Williams	24
3	Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis* 2010 ·Critical Care Medicine ·Michiel E. Stegenga, Jean‐Louis Vincent, G. Matthew Vail, (unknown), Douglas J. Haney, Mark D. Williams, Gordon R. Bernard, Tom van der Poll	101
4	Biomarkers of Thrombosis, Fibrinolysis, and Inflammation in Patients with Severe Sepsis due to Community-Acquired Pneumonia with and without Streptococcus pneumoniae 2009 ·Infection ·G. Matthew Vail, Yuanliang Xie, Douglas J. Haney, Christopher J. Barnes	27
5	Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated) 2008 ·Critical Care ·Andrew F. Shorr, David R. Nelson, Duncan Wyncoll, Konrad Reinhart, Frank M. Brunkhorst, G. Matthew Vail, Jonathan Janes	30
6	Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open‐label, crossover study 2007 ·British Journal of Urology ·Ian Eardley, Francesco Montorsi, Graham Jackson, Vincenzo Mirone, Melanie Chan, Kate Loughney, G. Matthew Vail, Anthony Beardsworth	30
7	Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing 2006 ·The American Journal of Cardiology ·Robert A. Kloner, Graham Jackson, Adolph M. Hutter, Murray A. Mittleman, Melanie Chan, Margaret R. Warner, Timothy M. Costigan, G. Matthew Vail	46
8	Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled study 2006 ·Urology ·Kōichi Nagao, Yasusuke Kimoto, Ken Marumo, Akira Tsujimura, G. Matthew Vail, Steven Watts, Nobuhisa Ishii, Sadao Kamidono	19
9	IN PATIENTS WITH SEVERE SEPSIS, RENAL DYSFUNCTION IS PREDICTED BY SEVERE PROTEIN C DEFICIENCY, WHICH IS IMPROVED BY DROTRECOGIN ALFA ACTIVATED THERAPY. 2006 ·Critical Care Medicine ·G. Matthew Vail, Dazhe Wang, William L. Macias, David R. Nelson, Mark D. Williams	2
10	Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area 2002 ·Transplant Infectious Disease ·G. Matthew Vail, R. S. Young, L. Joseph Wheat, Ronald S. Filo, Kenneth Cornetta, Martin H Goldman	80
11	Cellular Immune Response in HIV-Infected Patients With Histoplasmosis 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·G. Matthew Vail, (unknown), L. Joseph Wheat, (unknown), (unknown), Edward J. Brizendine, Carol Schnizlein‐Bick	5
12	Cellular Immune Response in HIV-Infected Patients With Histoplasmosis 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·G. Matthew Vail, (unknown), L. Joseph Wheat, (unknown), (unknown), Edward J. Brizendine, Carol Schnizlein‐Bick	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact